Alexza Pharmaceuticals Inc
ALXA
ALXA was delisted on the 16th of June, 2016.
38 hedge funds and large institutions have $15.2M invested in Alexza Pharmaceuticals Inc in 2014 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 8 closing their positions.
1,458% more call options, than puts
Call options by funds: $2.4M | Put options by funds: $154K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less funds holding
Funds holding: 40 → 38 (-2)
23% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 13
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
49% less capital invested
Capital invested by funds: $30M → $15.2M (-$14.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPA
Lansdowne Partners Austria
Vienna,
Austria
|
+$1.02M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$837K |
| 3 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$426K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$126K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$96.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$3.06M |
| 2 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$976K |
| 3 |
VM
VHCP Management
New York
|
-$674K |
| 4 |
BCM
BBT Capital Management
Fort Worth,
Texas
|
-$539K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$349K |
ALXA Hedge Fund Activity: Q3 2014 in Review
38 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Alexza Pharmaceuticals Inc (ALXA) for Q3 2014, worth a combined $15.2M — down 49% from $30M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ALXA and 6 opened new positions — a net loss of 2 holders — while 13 trimmed existing stakes and 10 added.
The largest buyer was Lansdowne Partners Austria, adding an estimated $1.02M. The largest seller was Federated Hermes, exiting entirely with an estimated $3.06M sold.
- 38 institutional investors held Alexza Pharmaceuticals Inc (ALXA) as of Q3 2014, down from 40 in Q2 2014.
- Funds reported $15.2M of Alexza Pharmaceuticals Inc stock for Q3 2014, down 49% quarter-over-quarter.
- 6 funds opened new Alexza Pharmaceuticals Inc positions in Q3 2014 and 8 closed out, a net change of -2 holders.
- The largest Alexza Pharmaceuticals Inc buyer in Q3 2014 was Lansdowne Partners Austria, an estimated $1.02M added.
- The largest Alexza Pharmaceuticals Inc seller in Q3 2014 was Federated Hermes, an estimated $3.06M sold.
Based on aggregated 13F filings for Q3 2014.